Current knowledge about biomarkers of acute kidney injury in liver cirrhosis

키워드

참고문헌 (156)

1. The Korean Association for the Study of the Liver, "KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications", Clinical and Molecular Hepatology, 26(2), pp.83~127 (2020), 대한간학회[DOI]
2. Ginès P, "Renal failure in cirrhosis", N Engl J Med, 361, pp.1279~1290 (2009)
3. Kamath PS, "A model to predict survival in patients with endstage liver disease", Hepatology, 33, pp.464~470 (2001)
4. Angeli P, "Diagnosis and management of acute kidney injury in patients with cirrhosis : revised consensus recommendations of the International Club of Ascites", Gut, 64, pp.531~537 (2015)
5. Allegretti AS, "Prognosis of acute kidney injury and hepatorenal syndrome in patients with cirrhosis : a prospective cohort study", Int J Nephrol, 2015, pp.108139~ (2015)
6. Belcher JM, "Association of AKI with mortality and complications in hospitalized patients with cirrhosis", Hepatology, 57, pp.753~762 (2013)
7. Fagundes C, "A modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis", J Hepatol, 59, pp.474~481 (2013)
8. Moreau R, "Acute renal failure in patients with cirrhosis : perspectives in the age of MELD", Hepatology, 37, pp.233~243 (2003)
9. Durand F, "Pathogenesis of hepatorenal syndrome : implications for therapy", Am J Kidney Dis, 67, pp.318~328 (2016)
10. Schrier RW, "Peripheral arterial vasodilation hypothesis : a proposal for the initiation of renal sodium and water retention in cirrhosis", Hepatology, 8, pp.1151~1157 (1988)
11. Yoo JJ, "Estimation of renal function in patients with liver cirrhosis : impact of muscle mass and sex", J Hepatol, 70, pp.847~854 (2019)
12. Rinaldo Bellomo, "Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group", Critical Care, 8(4), pp.204~212 (2004), Springer Science and Business Media LLC[DOI]
13. Cholongitas E, "RIFLE classification as predictive factor of mortality in patients with cirrhosis admitted to intensive care unit", J Gastroenterol Hepatol, 24, pp.1639~1647 (2009)
14. Jenq CC, "RIFLE classification can predict short-term prognosis in critically ill cirrhotic patients", Intensive Care Med, 33, pp.1921~1930 (2007)
15. Mehta RL, "Acute kidney injury network : report of an initiative to improve outcomes in acute kidney injury", Crit Care, 11, pp.R31~ (2007)
16. Tu KH, "Outcome scoring systems for short-term prognosis in critically ill cirrhotic patients", Shock, 36, pp.445~450 (2011)
17. Wong F, "Outcomes of patients with cirrhosis and hepatorenal syndrome type 1 treated with liver transplantation", Liver Transpl, 21, pp.300~307 (2015)
18. Paul E. Stevens, "Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline", Annals of Internal Medicine, 158(11), pp.825~830 (2013), American College of Physicians[DOI]
19. Nadim MK, "Simultaneous liver-kidney transplantation summit : current state and future directions", Am J Transplant, 12, pp.2901~2908 (2012)
20. Wong F, "New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection", Gastroenterology, 145, pp.1280~1288 (2013)
21. Angeli P, "Tubular site of renal sodium retention in ascitic liver cirrhosis evaluated by lithium clearance", Eur J Clin Invest, 20, pp.111~117 (1990)
22. Pan HC, "Acute Kidney Injury classification for critically Ill cirrhotic patients : a comparison of the KDIGO, AKIN, and RIFLE classifications", Sci Rep, 6, pp.23022~ (2016)
23. V Arroyo, "Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club", Hepatology, 23(1), pp.164~176 (1996), Ovid Technologies (Wolters Kluwer Health)[DOI]
24. Garcia-Tsao G, "Acute kidney injury in cirrhosis", Hepatology, 48, pp.2064~2077 (2008)
25. Ruiz-del-Arbol L, "Circulatory function and hepatorenal syndrome in cirrhosis", Hepatology, 42, pp.439~447 (2005)
26. Salerno F, "Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis", Gut, 56, pp.1310~1318 (2007)
27. Planas R, "Acetylsalicylic acid suppresses the renal hemodynamic effect and reduces the diuretic action of furosemide in cirrhosis with ascites", Gastroenterology, 84, pp.247~252 (1983)
28. Bernardi M, "Mechanisms of decompensation and organ failure in cirrhosis : from peripheral arterial vasodilation to systemic inflammation hypothesis", J Hepatol, 63, pp.1272~1284 (2015)
29. Francoz C, "Hepatorenal syndrome", Clin J Am Soc Nephrol, 14, pp.774~781 (2019)
30. Allegretti AS, "Siglec-7 as a novel biomarker to predict mortality in decompensated cirrhosis and acute kidney injury", Dig Dis Sci, 61, pp.3609~3620 (2016)
31. Solé C, "Characterization of inflammatory response in hepatorenal syndrome : relationship with kidney outcome and survival", Liver Int, 39, pp.1246~1255 (2019)
32. Ki Tae Yoon, "β-blockers in advanced cirrhosis: More friend than enemy", Clinical and Molecular Hepatology, 27(3), pp.425~436 (2021), 대한간학회[DOI]
33. Wiest R, "Pathological bacterial translocation in liver cirrhosis", J Hepatol, 60, pp.197~209 (2014)
34. Navasa M, "Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis : relationship with the development of renal impairment and mortality", Hepatology, 27, pp.1227~1232 (1998)
35. Moreau R, "Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis", Gastroenterology, 144, pp.1426~1437 (2013)
36. Maiwall R, "SIRS at admission is a predictor of AKI development and mortality in hospitalized patients with severe alcoholic hepatitis", Dig Dis Sci, 61, pp.920~929 (2016)
37. Shah N, "Prevention of acute kidney injury in a rodent model of cirrhosis following selective gut decontamination is associated with reduced renal TLR4 expression", J Hepatol, 56, pp.1047~1053 (2012)
38. Shah N, "Increased renal expression and urinary excretion of TLR4 in acute kidney injury associated with cirrhosis", Liver Int, 33, pp.398~409 (2013)
39. Emlet DR, "Sepsis-associated AKI : epithelial cell dysfunction", Semin Nephrol, 35, pp.85~95 (2015)
40. Maiwall R, "AKI in patients with acute on chronic liver failure is different from acute decompensation of cirrhosis", Hepatol Int, 9, pp.627~639 (2015)
41. Mehan MR, "Highly multiplexed proteomic platform for biomarker discovery, diagnostics, and therapeutics", Adv Exp Med Biol, 735, pp.283~300 (2013)
42. Blank M, "Biomarkers of druginduced acute kidney injury : a regulatory perspective", Expert Opin Drug Metab Toxicol, 14, pp.929~936 (2018)
43. Siew ED, "Biological markers of acute kidney injury", J Am Soc Nephrol, 22, pp.810~820 (2011)
44. Parikh CR, "Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery", J Am Soc Nephrol, 22, pp.1748~1757 (2011)
45. Mishra J, "Neutrophil gelatinase-associated lipocalin(NGAL)as a biomarker for acute renal injury after cardiac surgery", Lancet, 365, pp.1231~1238 (2005)
46. Koyner JL, "Biomarkers predict progression of acute kidney injury after cardiac surgery", J Am Soc Nephrol, 23, pp.905~914 (2012)
47. Arthur JM, "Evaluation of 32 urine biomarkers to predict the progression of acute kidney injury after cardiac surgery", Kidney Int, 85, pp.431~438 (2014)
48. Coca SG, "Urinary biomarkers of AKI and mortality 3years after cardiac surgery", J Am Soc Nephrol, 25, pp.1063~1071 (2014)
49. Koyner JL, "Tissue inhibitor metalloproteinase-2(TIMP-2)⋅IGF-binding protein-7(IGFBP7)levels are associated with adverse long-term outcomes in patients with AKI", J Am Soc Nephrol, 26, pp.1747~1754 (2015)
50. Srisawat N, "Urinary biomarkers and renal recovery in critically ill patients with renal support", Clin J Am Soc Nephrol, 6, pp.1815~1823 (2011)
51. Parikh CR, "Urinary interleukin-18 is a marker of human acute tubular necrosis", Am J Kidney Dis, 43, pp.405~414 (2004)
52. Parikh CR, "Acute kidney injury : defining prerenal azotemia in clinical practice and research", Nat Rev Nephrol, 6, pp.641~642 (2010)
53. Ronco C, "Acute kidney injury", Lancet, 394, pp.1949~1964 (2019)
54. Cocchetto DM, "Decreased rate of creatinine production in patients with hepatic disease : implications for estimation of creatinine clearance", Ther Drug Monit, 5, pp.161~168 (1983)
55. Mindikoglu AL, "Gender disparity in liver transplant waiting-list mortality : the importance of kidney function", Liver Transpl, 16, pp.1147~1157 (2010)
56. Maxine A. Papadakis, "Unpredictability of clinical evaluation of renal function in cirrhosis", The American Journal of Medicine, 82(5), pp.945~952 (1987), Elsevier BV[DOI]
57. Stevens LA, "Assessing kidney function--measured and estimated glomerular filtration rate", N Engl J Med, 354, pp.2473~2483 (2006)
58. Sherman DS, "Assessing renal function in cirrhotic patients : problems and pitfalls", Am J Kidney Dis, 41, pp.269~278 (2003)
59. Sherlock S, "Complications of diuretic therapy in hepatic cirrhosis", Lancet, 1, pp.1049~1052 (1966)
60. Caregaro L, "Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis", Arch Intern Med, 154, pp.201~205 (1994)
61. Gonwa TA, "Estimation of glomerular filtration rates before and after orthotopic liver transplantation : evaluation of current equations", Liver Transpl, 10, pp.301~309 (2004)
62. Sansoé G, "Inappropriately low angiotensin II generation : a factor determining reduced kidney function and survival in patients with decompensated cirrhosis", J Hepatol, 40, pp.417~423 (2004)
63. Thomas L, "Renal function--estimation of glomerular filtration rate", Clin Chem Lab Med, 44, pp.1295~1302 (2006)
64. Proulx NL, "Measured creatinine clearance from timed urine collections substantially overestimates glomerular filtration rate in patients with liver cirrhosis : a systematic review and individual patient meta-analysis", Nephrol Dial Transplant, 20, pp.1617~1622 (2005)
65. Francoz C, "The evaluation of renal function and disease in patients with cirrhosis", J Hepatol, 52, pp.605~613 (2010)
66. Orlando R, "Evaluation of measured and calculated creatinine clearances as glomerular filtration markers in different stages of liver cirrhosis", Clin Nephrol, 51, pp.341~347 (1999)
67. Cockcroft DW, "Prediction of creatinine clearance from serum creatinine", Nephron, 16, pp.31~41 (1976)
68. Levey AS, "A more accurate method to estimate glomerular filtration rate from serum creatinine : a new prediction equation. Modification of diet in renal disease study group", Ann Intern Med, 130, pp.461~470 (1999)
69. Levey AS, "Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values", Clin Chem, 53, pp.766~772 (2007)
70. Levey AS, "Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate", Ann Intern Med, 145, pp.247~254 (2006)
71. Levey AS, "A new equation to estimate glomerular filtration rate", Ann Intern Med, 150, pp.604~612 (2009)
72. C Davis, "Pathophysiology of renal disease associated with liver disorders: Implications for liver transplantation. Part I", Liver Transplantation, 8(2), pp.91~109 (2002), Ovid Technologies (Wolters Kluwer Health)[DOI]
73. Llach J, "Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites", Gastroenterology, 94, pp.482~487 (1988)
74. Piano S, "Evaluation of the acute kidney injury network criteria in hospitalized patients with cirrhosis and ascites", J Hepatol, 59, pp.482~489 (2013)
75. Seo YS, "Serum cystatin C level : an excellent predictor of mortality in patients with cirrhotic ascites", J Gastroenterol Hepatol, 33, pp.910~917 (2018)
76. Alessandria C, "MELD score and clinical type predict prognosis in hepatorenal syndrome : relevance to liver transplantation", Hepatology, 41, pp.1282~1289 (2005)
77. Francoz C, "Glomerular filtration rate equations for liver-kidney transplantation in patients with cirrhosis : validation of current recommendations", Hepatology, 59, pp.1514~1521 (2014)
78. Nair S, "Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation", Hepatology, 35, pp.1179~1185 (2002)
79. Simonsen O, "The blood serum concentration of cystatin C(gamma-trace)as a measure of the glomerular filtration rate", Scand J Clin Lab Invest, 45, pp.97~101 (1985)
80. Abrahamson M, "Structure and expression of the human cystatin C gene", Biochem J, 268, pp.287~294 (1990)
81. Tenstad O, "Renal handling of radiolabelled human cystatin C in the rat", Scand J Clin Lab Invest, 56, pp.409~414 (1996)
82. Mindikoglu AL, "Cystatin C is a gender-neutral glomerular filtration rate biomarker in patients with cirrhosis", Dig Dis Sci, 63, pp.665~675 (2018)
83. Cholongitas E, "Review article : renal function assessment in cirrhosis-difficulties and alternative measurements", Aliment Pharmacol Ther, 26, pp.969~978 (2007)
84. Gerbes AL, "Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver", Gut, 50, pp.106~110 (2002)
85. Filler G, "Cystatin C as a marker of GFR--history, indications, and future research", Clin Biochem, 38, pp.1~8 (2005)
86. Kiessling AH, "Early postoperative serum cystatin C predicts severe acute kidney injury following cardiac surgery : a post-hoc analysis of a randomized controlled trial", J Cardiothorac Surg, 9, pp.10~ (2014)
87. Mindikoglu AL, "Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis", Hepatology, 59, pp.1532~1542 (2014)
88. De Souza V, "Creatinine-versus cystatine C-based equations in assessing the renal function of candidates for liver transplantation with cirrhosis", Hepatology, 59, pp.1522~1531 (2014)
89. Maiwall R, "Cystatin C predicts acute kidney injury and mortality in cirrhotics : a prospective cohort study", Liver Int, 38, pp.654~664 (2018)
90. Slack AJ, "Predicting the development of acute kidney injury in liver cirrhosis--an analysis of glomerular filtration rate, proteinuria and kidney injury biomarkers", Aliment Pharmacol Ther, 37, pp.989~997 (2013)
91. Markwardt D, "Plasma cystatin C is a predictor of renal dysfunction, acuteon-chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis", Hepatology, 66, pp.1232~1241 (2017)
92. Moreau R, "Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome : a retrospective multicenter study", Gastroenterology, 122, pp.923~930 (2002)
93. Sharma P, "An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response", Am J Gastroenterol, 103, pp.1689~1697 (2008)
94. Sanyal AJ, "A randomized, prospective, double-blind, placebocontrolled trial of terlipressin for type 1 hepatorenal syndrome", Gastroenterology, 134, pp.1360~1368 (2008)
95. Boyer TD, "Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1", Liver Transpl, 17, pp.1328~1332 (2011)
96. Mariana Alves, "Análise da Revisão Cochrane: Alta Hospitalar Precoce para Hospitalização Domiciliária. Cochrane Database Syst Rev. 2017;6:CD000356", Acta Médica Portuguesa, 30(12), pp.835~839 (2017), Ordem dos Medicos[DOI]
97. Israelsen M, "Terlipressin versus other vasoactive drugs for hepatorenal syndrome", Cochrane Database Syst Rev (2017)
98. Waikar SS, "Imperfect gold standards for kidney injury biomarker evaluation", J Am Soc Nephrol, 23, pp.13~21 (2012)
99. Cabrera J, "Aminoglycoside nephrotoxicity in cirrhosis. Value of urinary beta 2-microglobulin to discriminate functional renal failure from acute tubular damage", Gastroenterology, 82, pp.97~105 (1982)
100. Pépin MN, "Diagnostic performance of fractional excretion of urea and fractional excretion of sodium in the evaluations of patients with acute kidney injury with or without diuretic treatment", Am J Kidney Dis, 50, pp.566~573 (2007)
101. Wadei HM, "Kidney allocation to liver transplant candidates with renal failure of undetermined etiology : role of percutaneous renal biopsy", Am J Transplant, 8, pp.2618~2626 (2008)
102. Malhotra R, "Biomarkers for the early detection and prognosis of acute kidney injury", Clin J Am Soc Nephrol, 12, pp.149~173 (2017)
103. Treeprasertsuk S, "Urine neutrophil gelatinaseassociated lipocalin : a diagnostic and prognostic marker for acute kidney injury(AKI)in hospitalized cirrhotic patients with AKI-prone conditions", BMC Gastroenterol, 15, pp.140~ (2015)
104. Yap DY, "Serum and urinary biomarkers that predict hepatorenal syndrome in patients with advanced cirrhosis", Dig Liver Dis, 49, pp.202~206 (2017)
105. Belcher JM, "Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury", Hepatology, 60, pp.622~632 (2014)
106. Verna EC, "Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis", Dig Dis Sci, 57, pp.2362~2370 (2012)
107. Huelin P, "Neutrophil gelatinase-associated lipocalin for assessment of acute kidney injury in cirrhosis : a prospective study", Hepatology, 70, pp.319~333 (2019)
108. Ariza X, "Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis", PLoS One, 10, pp.e0128145~ (2015)
109. Qasem AA, "Urinary biomarkers of acute kidney injury in patients with liver cirrhosis", ISRN Nephrol, 2014, pp.376795~ (2014)
110. Jaques DA, "Biomarkers for acute kidney injury in decompensated cirrhosis: a prospective study", Nephrology (Carlton), 24, pp.170~180 (2019)
111. Mishra J, "Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury", J Am Soc Nephrol, 14, pp.2534~2543 (2003)
112. Goetz DH, "The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition", Mol Cell, 10, pp.1033~1043 (2002)
113. Schmidt-Ott KM, "Dual action of neutrophil gelatinase-associated lipocalin", J Am Soc Nephrol, 18, pp.407~413 (2007)
114. Waring WS, "Earlier recognition of nephrotoxicity using novel biomarkers of acute kidney injury", Clin Toxicol(Phila), 49, pp.720~728 (2011)
115. Charlton JR, "A basic science view of acute kidney injury biomarkers", Nephrol Dial Transplant, 29, pp.1301~1311 (2014)
116. Bazzi C, "Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis", Nephrol Dial Transplant, 17, pp.1890~1896 (2002)
117. Li J, "Differential roles of dihydropyridine calcium antagonist nifedipine, nitrendipine and amlodipine on gentamicin-induced renal tubular toxicity in rats", Eur J Pharmacol, 620, pp.97~104 (2009)
118. Xu Z, "Effects of BSO, GSH, Vit-C and DMPS on the nephrotoxicity of mercury", Toxicol Ind Health, 23, pp.403~410 (2007)
119. Liu Y, "Urinary interleukin 18 for detection of acute kidney injury : a meta-analysis", Am J Kidney Dis, 62, pp.1058~1067 (2013)
120. Wu H, "IL-18contributes to renal damage after ischemia-reperfusion", J Am Soc Nephrol, 19, pp.2331~2341 (2008)
121. Tsai MH, "Acute renal failure in cirrhotic patients with severe sepsis : value of urinary interleukin-18", J Gastroenterol Hepatol, 28, pp.135~141 (2013)
122. Siew ED, "Elevated urinary IL-18 levels at the time of ICU admission predict adverse clinical outcomes", Clin J Am Soc Nephrol, 5, pp.1497~1505 (2010)
123. Jo SK, "Role of biomarkers as predictors of acute kidney injury and mortality in decompensated cirrhosis", Sci Rep, 9, pp.14508~ (2019)
124. Ichimura T, "Kidney injury molecule-1(KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is upregulated in renal cells after injury", J Biol Chem, 273, pp.4135~4142 (1998)
125. Han WK, "Kidney injury molecule-1(KIM-1) : a novel biomarker for human renal proximal tubule injury", Kidney Int, 62, pp.237~244 (2002)
126. Han WK, "Urinary biomarkers in the early diagnosis of acute kidney injury", Kidney Int, 73, pp.863~869 (2008)
127. Furuhashi M, "Fatty acid-binding proteins : role in metabolic diseases and potential as drug targets", Nat Rev Drug Discov, 7, pp.489~503 (2008)
128. Kamijo-Ikemori A, "Roles of human liver type fatty acid binding protein in kidney disease clarified using hL-FABP chromosomal transgenic mice", Nephrology(Carlton), 16, pp.539~544 (2011)
129. Doi K, "Urinary L-type fatty acid-binding protein as a new biomarker of sepsis complicated with acute kidney injury", Crit Care Med, 38, pp.2037~2042 (2010)
130. Yamamoto T, "Renal L-type fatty acid--binding protein in acute ischemic injury", J Am Soc Nephrol, 18, pp.2894~2902 (2007)
131. Xu Y, "L-FABP : a novel biomarker of kidney disease", Clin Chim Acta, 445, pp.85~90 (2015)
132. Wagener G, "Association between increases in urinary neutrophil gelatinaseassociated lipocalin and acute renal dysfunction after adult cardiac surgery", Anesthesiology, 105, pp.485~491 (2006)
133. Makris K, "Urinary neutrophil gelatinase-associated lipocalin(NGAL)as an early marker of acute kidney injury in critically ill multiple trauma patients", Clin Chem Lab Med, 47, pp.79~82 (2009)
134. Nickolas TL, "Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury", Ann Intern Med, 148, pp.810~819 (2008)
135. Fagundes C, "Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis", J Hepatol, 57, pp.267~273 (2012)
136. Mårtensson J, "The rise and fall of NGAL in acute kidney injury", Blood Purif, 37, pp.304~310 (2014)
137. Ostermann M, "Biomarkers for AKI improve clinical practice : no", Intensive Care Med, 41, pp.618~622 (2015)
138. Macdonald SP, "Sustained elevation of resistin, NGAL and IL-8are associated with severe sepsis", septic shock in the emergency department, 2014, pp.9, e110678~
139. Otto GP, "Impact of sepsis-associated cytokine storm on plasma NGAL during acute kidney injury in a model of polymicrobial sepsis", Crit Care, 17, pp.419~ (2013)
140. Kim TH, "Prognosis predictability of serum and urine renal markers in patients with decompensated cirrhosis : a multicentre prospective study", Liver Int, 40, pp.3083~3092 (2020)
141. Barreto R, "Urinary neutrophil gelatinase-associated lipocalin predicts kidney outcome and death in patients with cirrhosis and bacterial infections", J Hepatol, 61, pp.35~42 (2014)
142. Puthumana J, "Urine interleukin 18 and lipocalin 2 are biomarkers of acute tubular necrosis in patients with cirrhosis : a systematic review and metaanalysis", Clin Gastroenterol Hepatol, 15, pp.1003~1013 (2017)
143. Seo DW, "TIMP-2 mediated inhibition of angiogenesis : an MMP-independent mechanism", Cell, 114, pp.171~180 (2003)
144. for acute kidney injury risk assessment, "Am J Kidney Dis", 2016, 19~28
145. Hwa V, "The insulin-like growth factor-binding protein(IGFBP)superfamily", Endocr Rev, 20, pp.761~787 (1999)
146. Kashani K, "Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury", Crit Care, 17, pp.R25~ (2013)
147. in patients with hepatorenal syndrome, "Biomarkers", 2019, 692~699
148. Garg H, "Clinical profile and predictors of mortality in patients of acute-on-chronic liver failure", Dig Liver Dis, 44, pp.166~171 (2012)
149. Jindal A, "Evaluation of acute kidney injury and its response to terlipressin in patients with acuteon-chronic liver failure", Liver Int, 36, pp.59~67 (2016)
150. Maiwall R, "Incidence, risk factors, and outcomes of transition of acute kidney injury to chronic kidney disease in cirrhosis : a prospective cohort study", Hepatology, 71, pp.1009~1022 (2020)
151. Wan ZH, "Cystatin C is a biomarker for predicting acute kidney injury in patients with acute-on-chronic liver failure", World J Gastroenterol, 19, pp.9432~9438 (2013)
152. Ariza X, "Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis", J Hepatol, 65, pp.57~65 (2016)
153. Grønbaek H, "Improved prediction of mortality by combinations of inflammatory markers and standard clinical scores in patients with acuteon-chronic liver failure and acute decompensation", J Gastroenterol Hepatol, 36, pp.240~248 (2021)
154. Maiwall R, "Acute kidney injury in acute on chronic liver failure", Hepatol Int, 10, pp.245~257 (2016)
155. Chawla LS, "Acute kidney injury and chronic kidney disease as interconnected syndromes", N Engl J Med, 371, pp.58~66 (2014)
156. Belcher JM, "Urinary biomarkers and progression of AKI in patients with cirrhosis", Clin J Am Soc Nephrol, 9, pp.1857~1867 (2014)

관련 논문AI추천